Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.

Identifieur interne : 000A85 ( Ncbi/Merge ); précédent : 000A84; suivant : 000A86

Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.

Auteurs : Jenny Blechinger [Allemagne] ; Hanna Pieper ; Paul Marzenell ; Larisa Kovbasyuk ; Andrius Serva ; Vytaute Starkuviene ; Holger Erfle ; Andriy Mokhir

Source :

RBID : pubmed:23863995

Descripteurs français

English descriptors

Abstract

We applied 14-mer 2'-OMe RNAs as inhibitors of selected micro RNAs. To improve their properties, we introduced a trimethoxystilbene residue at the 5'-terminus and three 2'-fluoro-2'-deoxynucleotides at the 3'-terminus to obtain potent inhibitors, whose mismatch discrimination is substantially better than that of typically applied >18-mers.

DOI: 10.1039/c3cc43174f
PubMed: 23863995

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:23863995

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.</title>
<author>
<name sortKey="Blechinger, Jenny" sort="Blechinger, Jenny" uniqKey="Blechinger J" first="Jenny" last="Blechinger">Jenny Blechinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nuremberg, Henkestr. 42, 91054 Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nuremberg, Henkestr. 42, 91054 Erlangen</wicri:regionArea>
<wicri:noRegion>91054 Erlangen</wicri:noRegion>
<placeName>
<settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pieper, Hanna" sort="Pieper, Hanna" uniqKey="Pieper H" first="Hanna" last="Pieper">Hanna Pieper</name>
</author>
<author>
<name sortKey="Marzenell, Paul" sort="Marzenell, Paul" uniqKey="Marzenell P" first="Paul" last="Marzenell">Paul Marzenell</name>
</author>
<author>
<name sortKey="Kovbasyuk, Larisa" sort="Kovbasyuk, Larisa" uniqKey="Kovbasyuk L" first="Larisa" last="Kovbasyuk">Larisa Kovbasyuk</name>
</author>
<author>
<name sortKey="Serva, Andrius" sort="Serva, Andrius" uniqKey="Serva A" first="Andrius" last="Serva">Andrius Serva</name>
</author>
<author>
<name sortKey="Starkuviene, Vytaute" sort="Starkuviene, Vytaute" uniqKey="Starkuviene V" first="Vytaute" last="Starkuviene">Vytaute Starkuviene</name>
</author>
<author>
<name sortKey="Erfle, Holger" sort="Erfle, Holger" uniqKey="Erfle H" first="Holger" last="Erfle">Holger Erfle</name>
</author>
<author>
<name sortKey="Mokhir, Andriy" sort="Mokhir, Andriy" uniqKey="Mokhir A" first="Andriy" last="Mokhir">Andriy Mokhir</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23863995</idno>
<idno type="pmid">23863995</idno>
<idno type="doi">10.1039/c3cc43174f</idno>
<idno type="wicri:Area/PubMed/Corpus">001C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C53</idno>
<idno type="wicri:Area/PubMed/Curation">001C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C53</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A64</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A64</idno>
<idno type="wicri:Area/Ncbi/Merge">000A85</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.</title>
<author>
<name sortKey="Blechinger, Jenny" sort="Blechinger, Jenny" uniqKey="Blechinger J" first="Jenny" last="Blechinger">Jenny Blechinger</name>
<affiliation wicri:level="1">
<nlm:affiliation>Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nuremberg, Henkestr. 42, 91054 Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nuremberg, Henkestr. 42, 91054 Erlangen</wicri:regionArea>
<wicri:noRegion>91054 Erlangen</wicri:noRegion>
<placeName>
<settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Pieper, Hanna" sort="Pieper, Hanna" uniqKey="Pieper H" first="Hanna" last="Pieper">Hanna Pieper</name>
</author>
<author>
<name sortKey="Marzenell, Paul" sort="Marzenell, Paul" uniqKey="Marzenell P" first="Paul" last="Marzenell">Paul Marzenell</name>
</author>
<author>
<name sortKey="Kovbasyuk, Larisa" sort="Kovbasyuk, Larisa" uniqKey="Kovbasyuk L" first="Larisa" last="Kovbasyuk">Larisa Kovbasyuk</name>
</author>
<author>
<name sortKey="Serva, Andrius" sort="Serva, Andrius" uniqKey="Serva A" first="Andrius" last="Serva">Andrius Serva</name>
</author>
<author>
<name sortKey="Starkuviene, Vytaute" sort="Starkuviene, Vytaute" uniqKey="Starkuviene V" first="Vytaute" last="Starkuviene">Vytaute Starkuviene</name>
</author>
<author>
<name sortKey="Erfle, Holger" sort="Erfle, Holger" uniqKey="Erfle H" first="Holger" last="Erfle">Holger Erfle</name>
</author>
<author>
<name sortKey="Mokhir, Andriy" sort="Mokhir, Andriy" uniqKey="Mokhir A" first="Andriy" last="Mokhir">Andriy Mokhir</name>
</author>
</analytic>
<series>
<title level="j">Chemical communications (Cambridge, England)</title>
<idno type="eISSN">1364-548X</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Base Sequence</term>
<term>Down-Regulation (drug effects)</term>
<term>HeLa Cells</term>
<term>Humans</term>
<term>MicroRNAs (antagonists & inhibitors)</term>
<term>MicroRNAs (chemistry)</term>
<term>Oligonucleotides (chemistry)</term>
<term>Oligonucleotides (pharmacology)</term>
<term>Stilbenes (chemistry)</term>
<term>Stilbenes (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cellules HeLa</term>
<term>Humains</term>
<term>Oligonucléotides ()</term>
<term>Oligonucléotides (pharmacologie)</term>
<term>Régulation négative ()</term>
<term>Stilbènes ()</term>
<term>Stilbènes (pharmacologie)</term>
<term>Séquence nucléotidique</term>
<term>microARN ()</term>
<term>microARN (antagonistes et inhibiteurs)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>MicroRNAs</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>MicroRNAs</term>
<term>Oligonucleotides</term>
<term>Stilbenes</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>microARN</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Down-Regulation</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Oligonucléotides</term>
<term>Stilbènes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Oligonucleotides</term>
<term>Stilbenes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Base Sequence</term>
<term>HeLa Cells</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cellules HeLa</term>
<term>Humains</term>
<term>Oligonucléotides</term>
<term>Régulation négative</term>
<term>Stilbènes</term>
<term>Séquence nucléotidique</term>
<term>microARN</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We applied 14-mer 2'-OMe RNAs as inhibitors of selected micro RNAs. To improve their properties, we introduced a trimethoxystilbene residue at the 5'-terminus and three 2'-fluoro-2'-deoxynucleotides at the 3'-terminus to obtain potent inhibitors, whose mismatch discrimination is substantially better than that of typically applied >18-mers.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">23863995</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>02</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>07</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1364-548X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>49</Volume>
<Issue>67</Issue>
<PubDate>
<Year>2013</Year>
<Month>Aug</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>Chemical communications (Cambridge, England)</Title>
<ISOAbbreviation>Chem. Commun. (Camb.)</ISOAbbreviation>
</Journal>
<ArticleTitle>Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.</ArticleTitle>
<Pagination>
<MedlinePgn>7397-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1039/c3cc43174f</ELocationID>
<Abstract>
<AbstractText>We applied 14-mer 2'-OMe RNAs as inhibitors of selected micro RNAs. To improve their properties, we introduced a trimethoxystilbene residue at the 5'-terminus and three 2'-fluoro-2'-deoxynucleotides at the 3'-terminus to obtain potent inhibitors, whose mismatch discrimination is substantially better than that of typically applied >18-mers.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Blechinger</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nuremberg, Henkestr. 42, 91054 Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pieper</LastName>
<ForeName>Hanna</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marzenell</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kovbasyuk</LastName>
<ForeName>Larisa</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Serva</LastName>
<ForeName>Andrius</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Starkuviene</LastName>
<ForeName>Vytaute</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Erfle</LastName>
<ForeName>Holger</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mokhir</LastName>
<ForeName>Andriy</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Chem Commun (Camb)</MedlineTA>
<NlmUniqueID>9610838</NlmUniqueID>
<ISSNLinking>1359-7345</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009841">Oligonucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013267">Stilbenes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009841" MajorTopicYN="N">Oligonucleotides</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013267" MajorTopicYN="N">Stilbenes</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>2</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23863995</ArticleId>
<ArticleId IdType="doi">10.1039/c3cc43174f</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bavière</li>
<li>District de Moyenne-Franconie</li>
</region>
<settlement>
<li>Erlangen</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Erfle, Holger" sort="Erfle, Holger" uniqKey="Erfle H" first="Holger" last="Erfle">Holger Erfle</name>
<name sortKey="Kovbasyuk, Larisa" sort="Kovbasyuk, Larisa" uniqKey="Kovbasyuk L" first="Larisa" last="Kovbasyuk">Larisa Kovbasyuk</name>
<name sortKey="Marzenell, Paul" sort="Marzenell, Paul" uniqKey="Marzenell P" first="Paul" last="Marzenell">Paul Marzenell</name>
<name sortKey="Mokhir, Andriy" sort="Mokhir, Andriy" uniqKey="Mokhir A" first="Andriy" last="Mokhir">Andriy Mokhir</name>
<name sortKey="Pieper, Hanna" sort="Pieper, Hanna" uniqKey="Pieper H" first="Hanna" last="Pieper">Hanna Pieper</name>
<name sortKey="Serva, Andrius" sort="Serva, Andrius" uniqKey="Serva A" first="Andrius" last="Serva">Andrius Serva</name>
<name sortKey="Starkuviene, Vytaute" sort="Starkuviene, Vytaute" uniqKey="Starkuviene V" first="Vytaute" last="Starkuviene">Vytaute Starkuviene</name>
</noCountry>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Blechinger, Jenny" sort="Blechinger, Jenny" uniqKey="Blechinger J" first="Jenny" last="Blechinger">Jenny Blechinger</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A85 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000A85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:23863995
   |texte=   Short, terminally modified 2'-OMe RNAs as inhibitors of microRNA.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:23863995" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021